Stay updated with the latest zydus-lifesciences news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on zydus-lifesciences topics.
Ahmedabad: Zydus Lifesciences has expanded its presence in the U.S. generics market with a key regulatory approval for a widely used diabetes treatment. Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Dapagliflozin Tablets in 5 mg and 10 mg strengths. This approval enables the company to enter the U.S. market with a generic version of the drug, broadening its portfolio in a high-demand therapeutic category. With the approval, Zydus ...Read More >
New Delhi, Apr 8 (PTI) Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of dapagliflozin tablets indicated to control blood sugar in adults with type 2 diabetes mellitus. The approval by the US Food and Drug Administration (USFDA) is for dapagliflozin tablets of strengths 5 mg and 10 mg, Zydus Lifesciences said in a regulatory filing. Dapagliflozin is indicated as an adjunct to diet and exercise to improve glycaemic co ...Read More >
Pune (Maharashtra) [India], April 6 (ANI): Marking its much-awaited return after seven years, the Zydus Pinkathon Pune brought together over 4500 women at the AFMC Ground on Sunday, reaffirming the city's deep-rooted running culture and growing commitment to women's health and fitness. According to a release, the event commenced in the early hours and featured race categories ranging from 3 km, lifelong 5 km, and 10 km to ultra-distances of 50 km, 75 km, 100 km, and a 100 km relay, welcoming pa ...Read More >
Pune (Maharashtra) [India], April 6 (ANI): Marking its much-awaited return after seven years, the Zydus Pinkathon Pune brought together over 4500 women at the AFMC Ground on Sunday, reaffirming the city's deep-rooted running culture and growing commitment to women's health and fitness. According to a release, the event commenced in the early hours and featured race categories ranging from 3 km, lifelong 5 km, and 10 km to ultra-distances of 50 km, 75 km, 100 km, and a 100 km relay, welcoming pa ...Read More >
Three schools in Ahmedabad received bomb threat emails on Wednesday, prompting immediate police deployment and security checks. The emails, stating "We will take revenge," led to investigations, similar to recent hoax threats in Amritsar and Delhi, one of which referenced the Khalistan movement. On Wednesday, three schools in Ahmedabad received bomb threat emails, triggering swift police action. Officers were deployed to the campuses to ensure public safety, the Joint Police Commissioner said. ...Read More >
Mumbai (Maharashtra) [India], December 16 (ANI): Domestic stock markets continued to remain under pressure on Tuesday as both key benchmark indices opened in the red, weighed down by persistent foreign fund outflows and continued weakness in the rupee. At the opening bell, the Nifty 50 index started the day at 25,951.50, slipping by 75.80 points or 0.29 per cent. The BSE Sensex also opened lower at 85,025.61, down by 187.75 points or 0.22 per cent. Also Read | VB-G RAM G Bill 2025: 5 Key Chang ...Read More >
(RTTNews) - Indian shares opened on a sluggish note Tuesday, with lingering uncertainty around tariffs and caution ahead of key U.S. jobs and inflation data due this week keeping investors on edge. The benchmark BSE Sensex dropped 353 points, or 0.4 percent, to 84,859 while the broader NSE Nifty index was down 106 points, or 0.4 percent, at 25,914. Tata Power was down about 1 percent after it unveiled plans to invest around Rs. 25,000 crore in capital expenditure during the current financial y ...Read More >
New Delhi [India], December 16 (ANI): The Indira Gandhi International (IGI) Airport on Tuesday morning issued a fog advisory, warning passengers of possible disruptions to flight operations amid reduced visibility in the national capital. In a post shared on X at around 6:06 AM, Delhi Airport said, "Flight operations are steadily recovering, but disruptions may persist for certain departures and arrivals." Also Read | VB-G RAM G Bill 2025: 5 Key Changes in India's Rural Employment Law Replacin ...Read More >
New Delhi [India], December 16 (ANI): Union Minister of Commerce and Industry Piyush Goyal held discussions with Tatsuo Yasunaga, Chairman of the Japan-India Business Cooperation Committee (JIBCC), to explore ways to further strengthen trade and economic ties between India and Japan. In a social media post, the Commerce Minister said that he had a productive discussion with Tatsuo Yasunaga and his delegation. Also Read | VB-G RAM G Bill 2025: 5 Key Changes in India's Rural Employment Law Repla ...Read More >
Shimla (Himachal Pradesh) [India], December 16 (ANI): In the Sanjauli mosque case in Himachal Pradesh's capital Shimla, members of the Dev Bhoomi Hindu Sangharsh Samiti on Monday submitted a memorandum to the Municipal Corporation (MC) Commissioner, demanding immediate implementation of the High Court's orders directing the demolition of the remaining two unauthorized floors of the mosque. The organisation demanded that the demolition be carried out by December 29, in compliance with court dire ...Read More >
Mumbai: Less than a month after Ozempic maker Novo Nordisk announced it is cutting its global workforce as part of a restructuring plan, the layoffs have hit Indian employees in Bengaluru. Junior- to mid-level employees across functions such as sales and marketing, as well as those in the company's global business services (GBS) hub, which works with its global teams, have been impacted, according to at least three people aware of the development. "At least 100-150 will be retrenched from the ...Read More >
The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel of Zydus Lifesciences as its new President, with Glenn Saldanha of Glenmark as Vice President. This leadership transition occurs as the industry navigates GST reforms and strengthens its global position in specialty medicines. The new team aims to drive innovation, patient access, and quality healthcare solutions. The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel, Managing Director of Zydus Lifesciences as i ...Read More >
New Delhi, Sep 26 (PTI) US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 is unlikely to have an immediate impact on Indian exports, as it will affect only patented and branded products, not generic medicines, pharma industry players said on Friday. Indian Pharmaceutical Alliance (IPA), which represents 23 leading Indian pharmaceutical firms, including Dr Reddy's Laboratories, Sun Pharma, Lupin and Zydus Lifesciences, noted that Trump' ...Read More >
New Delhi: US President Donald Trump's decision to impose 100% tariffs on branded and patented drug exports has shaken Indian pharmaceutical markets, despite most of India's $10 billion US sales being in generics. The uncertainty lies in whether complex generics and specialty medicines will be included, a move that could directly impact leading players like Sun Pharma, Dr. Reddy's, Cipla, Zydus Lifesciences, and others. Stocks Facing Highest Exposure Dr. Reddy's emerges as the most vulnerable, ...Read More >
New Delhi, Sep 26 (PTI) Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines. Reacting to the development, IPA Secretary General Sudarshan Jain said in a statement, "It is not applicable to generics medicines." Trump's statement refers to patented and branded products supplied to US, he added. In his post on social me ...Read More >
New Delhi [India], September 26 (ANI): United States President Donald Trump announced on Friday that his administration will impose a 100 per cent tariff on branded and patented pharmaceutical products beginning October 1, 2025, unless the manufacturing companies establish production facilities in the United States. The Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK. ...Read More >
NEW DELHI: Pharma promoters may be competing fiercely in the market, but on Thursday they all rallied behind domestically- manufactured vaccines, including those for polio and Covid-19. Satish Reddy, chairman of Dr Reddy's Laboratories, Dilip Shanghvi, promoter and CMD of Sun Pharma, Pankaj Patel chairman and promoter of Zydus Lifesciences, and Torrent Pharma chairman Samir Mehta -- industry leaders known for their media reticence -- each took to social media platforms to endorse India-made vacc ...Read More >
NEW DELHI: The Nifty Pharma index closed on a positive note on Tuesday. Shares of Laurus Labs Ltd.(up 2.93 per cent), Gland Pharma Ltd.(up 2.43 per cent), Biocon Ltd.(up 1.92 per cent), Zydus Lifesciences Ltd.(up 1.27 per cent) and Lupin Ltd.(up 1.19 per cent) ended the day as top gainers in the pack. On the other hand, Abbott India Ltd.(down 2.82 per cent), Ajanta Pharma Ltd.(down 2.78 per cent), J B Chemicals & Pharmaceuticals Ltd.(down 2.01 per cent), Alkem Laboratories Ltd.(down 1.83 per c ...Read More >
AHMEDABAD: Homegrown pharma major, Zydus Lifesciences Limited, on Tuesday reported a 17.3% rise in consolidated net profit for FY 2025 at Rs 4,525.5 crore, up from Rs 3,859.5 crore in the previous year, driven by strong US and India sales. The board recommended a final dividend of Rs 11 per equity share, subject to shareholder approval at the AGM on 12 August 2025.For the March quarter (Q4), net profit fell marginally by 1.0% to Rs 1,170.9 crore from Rs 1,182.3 crore a year earlier, impacted by ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.